First-line treatment of Waldenström's disease with cladribine

被引：0

作者：

M. A. Fridrik

G. Jäger

C. Baldinger

O. Krieger

A. Chott

P. Bettelheim

机构：

[1] First Department of Medicine,

[2] AÖKh-Linz,undefined

[3] Krankenhausstrasse 9,undefined

[4] A-4020 Linz,undefined

[5] Austria,undefined

[6] Department of Medicine,undefined

[7] University of Graz,undefined

[8] Austria,undefined

[9] Third Department of Medicine,undefined

[10] AÖKh-Barmherzige Schwestern,undefined

[11] Wels,undefined

[12] Austria,undefined

[13] First Department of Medicine,undefined

[14] AÖKh Elisabethinen,undefined

[15] Linz,undefined

[16] Austria,undefined

[17] Department of Clinical Pathology,undefined

[18] University of Vienna,undefined

[19] Austria,undefined

[20] Central Laboratory,undefined

[21] AÖKh-Linz,undefined

[22] Austria,undefined

来源：

Annals of Hematology | 1997年 / 74卷

关键词：

Key words Waldenström's disease; Low-grade; NHL; 2-CdA; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Purpose: To assess the activity and side effects of cladribine (2-CdA) treatment in patients with advanced Waldenström's disease.

引用

页码：7 / 10

页数：3